Status:
RECRUITING
A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Polyneuropathy
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical study is to evaluate a new process for assessing and alleviating chemotherapy-induced peripheral neuropathy in the feet in patients treated with chemotherapy for early stage ...
Detailed Description
Background and Rationale This study aims to develop and evaluate a structured multidisciplinary rehabilitation process for assessing and managing chemotherapy-induced peripheral neuropathy in the fee...
Eligibility Criteria
Inclusion
- Patients with breast cancer receiving treatment at the Oncology Department, Sahlgrenska University Hospital (SU).
- Have undergone treatment with taxanes.
- Aged 18 years or older.
- Able to understand spoken and written Swedish.
- Patients who can ambulate with or without assistive walking devices.
- CTCAE grading above 2 at a medical visit after completing treatment.
Exclusion
- Bilateral amputation at the thigh level.
- Previously diagnosed neurological disease or neurological impairment affecting the feet.
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06904989
Start Date
December 1 2024
End Date
October 1 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45